OptimizeRx (OPRX) News Today → The biggest energy story ever? (From Porter & Company) (Ad) Free OPRX Stock Alerts $10.42 +0.22 (+2.16%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Reaffirmed for AbbVie: Future Growth Beyond Humira’s Competitionmarkets.businessinsider.com - April 29 at 7:12 PMFederated Hermes Inc. Has $2.62 Million Holdings in OptimizeRx Co. (NASDAQ:OPRX)marketbeat.com - April 28 at 5:20 AMOptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ETglobenewswire.com - April 26 at 7:30 AMFinancial Comparison: OptimizeRx (NASDAQ:OPRX) & ICTS International (OTCMKTS:ICTSF)americanbankingnews.com - April 22 at 1:12 AMOptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Reportglobenewswire.com - April 18 at 7:30 AMOptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP Securitiesmarketbeat.com - April 16 at 12:04 PMOptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - April 16 at 7:00 AMOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Rowstockhouse.com - April 13 at 12:40 AMOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Rowfinance.yahoo.com - April 11 at 9:21 AMOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Rowfinance.yahoo.com - April 11 at 9:21 AMOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Rowglobenewswire.com - April 11 at 7:30 AM7 Top Undervalued Stocks Primed for a Multibagger Recoveryinvestorplace.com - April 6 at 6:00 AMOptimizeRx: A Strong Buy on Strategic Acquisitions and Innovative Platform Expansionmarkets.businessinsider.com - April 4 at 8:50 AMJMP Securities Begins Coverage on OptimizeRx (NASDAQ:OPRX)marketbeat.com - April 4 at 8:31 AMTesla blames sales drop on Houthi attacks and arson in Germanyau.lifestyle.yahoo.com - April 2 at 5:24 PMAriana Madix To Host ‘Love Island USA’ as Sarah Hyland Departs Franchisemsn.com - April 1 at 8:53 PMCanoo spent double its annual revenue on the CEO’s private jet in 2023au.news.yahoo.com - April 1 at 8:53 PMOptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 3:52 PMOptimizeRx (NASDAQ:OPRX) Stock Rating Reaffirmed by Stifel Nicolausmarketbeat.com - April 1 at 12:23 PMQ4 2023 OPTIMIZERx Corp Earnings Callfinance.yahoo.com - March 29 at 7:57 AMOPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023investorplace.com - March 28 at 11:31 PMOptimizeRx Q4 revenue $28.4Mmsn.com - March 28 at 3:24 PMOptimizeRx Q4 2023 Earnings Previewmsn.com - March 27 at 2:32 PM7OPRX : OptimizeRx Earnings Previewbenzinga.com - March 27 at 2:32 PMOptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ETglobenewswire.com - March 25 at 7:30 AMOptimizeRx: Exponential Growth Drives The Valuation Cheaperseekingalpha.com - March 23 at 7:19 AMAnalysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)markets.businessinsider.com - March 13 at 2:21 PMOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023markets.businessinsider.com - March 11 at 7:50 PMOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023globenewswire.com - March 11 at 4:30 PMKennedy Capital Management LLC Buys Shares of 555,675 OptimizeRx Co. (NASDAQ:OPRX)marketbeat.com - March 8 at 7:45 AMOptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effortstockhouse.com - March 6 at 4:11 PMOptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effortglobenewswire.com - March 4 at 3:51 PMOptimizeRx Co. (NASDAQ:OPRX) Stock Holdings Lowered by Avenir Corpmarketbeat.com - March 2 at 12:17 PMOptimizeRx Stock (NASDAQ:OPRX), Short Interest Reportbenzinga.com - February 23 at 1:58 PMOptimizeRx to Participate in Upcoming Investor Conferencesglobenewswire.com - February 21 at 7:30 AMOptimizeRx Co. (NASDAQ:OPRX) Short Interest Down 19.6% in Januarymarketbeat.com - February 13 at 11:28 AMOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - January 28 at 4:32 AMJacob Asset Management of New York LLC Buys 85,720 Shares of OptimizeRx Co. (NASDAQ:OPRX)marketbeat.com - January 17 at 9:02 AMBrokers Issue Forecasts for OptimizeRx Co.'s FY2023 Earnings (NASDAQ:OPRX)marketbeat.com - January 12 at 6:36 AMOptimizeRx Co. (NASDAQ:OPRX) General Counsel Marion Odence-Ford Sells 4,000 Sharesmarketbeat.com - January 11 at 6:49 PMQ4 2024 Earnings Forecast for OptimizeRx Co. Issued By William Blair (NASDAQ:OPRX)marketbeat.com - January 11 at 8:26 AMRoyal Bank of Canada Raises OptimizeRx (NASDAQ:OPRX) Price Target to $17.00marketbeat.com - January 10 at 10:20 AMOptimizeRx Corporation: OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Updatefinanznachrichten.de - January 9 at 10:32 AMOptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Updatefinance.yahoo.com - January 9 at 10:32 AMBarclays Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight Recommendationmsn.com - January 4 at 1:43 AMBarclays Initiates Coverage on OptimizeRx (NASDAQ:OPRX)marketbeat.com - January 3 at 8:30 AMOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Buy" by Analystsmarketbeat.com - January 3 at 8:25 AMOptimizeRx initiated with neutral view at Barclaysrealmoney.thestreet.com - January 3 at 5:43 AMShould You Exit OptimizeRx Corp. (OPRX)?finance.yahoo.com - December 26 at 7:35 AMOptimizeRx Stock (NASDAQ:OPRX) Dividends: History, Yield and Datesbenzinga.com - December 23 at 9:00 AM Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. OPRX Media Mentions By Week OPRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPRX News Sentiment▼0.480.37▲Average Computer and Technology News Sentiment OPRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPRX Articles This Week▼52▲OPRX Articles Average Week Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ZeroFox News DHI Group News Steel Connect News Rimini Street News Edgio News Marchex News Emerald News Resources Connection News Zhihu News Gravity News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPRX) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.